We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Patterson Companies (PDCO) in Q4 Earnings?
Read MoreHide Full Article
Patterson Companies, Inc.’s (PDCO - Free Report) fourth-quarter fiscal 2019 results are expected to release on Jun 27, before the market opens. While its core segments — Patterson Dental and Animal Health — are expected to impress, a narrowed guidance for fiscal 2019 raises concern.
The company has a negative average earnings surprise of 4.4% in the trailing four quarters.
Which Way are Estimates Headed?
For the quarter to be reported, the Zacks Consensus Estimate for revenues is pegged at $1.43 billion, suggesting growth of 2% from the year-ago reported number. The same for earnings is pinned at 40 cents, indicating a decline of 33.3% from the year-ago reported figure.
We expect consumable and private label businesses to see robust growth in the fiscal fourth quarter, thereby driving Patterson Companies’ core Animal Health segment.
Notably, management is constantly adding new capabilities to strengthen the Animal Health arm. The company has been capitalizing on significant market opportunity in Animal Health by offering a full and comprehensive suite of solutions that allow veterinarians to offer all methods of serving their customers, including home delivery with tools that drive greater levels of compliance. This is expected to drive fiscal fourth-quarter results.
Coming to Patterson Dental, the segment saw year-over-year rise in revenues in the last reported quarter, after more than two years of dismal performance. This reflects that management has been stabilizing the unit through continued investments. Additionally, the dental portfolio is also witnessing a robust demand currently.
However, a narrowed guidance for fiscal 2019 earnings per share is worrisome.
Notably, the company now expects the metric to be $1.40-$1.45 compared with the previously communicated $1.40-$1.50.
We believe that stiff competition from Henry Schein Dental, a unit of Henry Schein (HSIC - Free Report) , and pricing pressures pose as headwinds for the company.
What Does Our Model Say?
Per our proven model, a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) to deliver a positive earnings surprise in the quarter. However, this is not the case here.
Earnings ESP: Patterson Companies has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Patterson Companies currently carries a Zacks Rank #3.
Please note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revision.
Peer Releases
Here are two stocks that reported solid results in this earnings season.
Stryker Corporation (SYK - Free Report) delivered first-quarter 2019 adjusted earnings per share of $1.88, beating the Zacks Consensus Estimate by 2.2%. Revenues of $3.52 billion were in line with the Zacks Consensus Estimate. The stock presently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
DENTSPLY SIRONA Inc. (XRAY - Free Report) reported adjusted earnings per share of 49 cents in the first quarter of 2019, beating the Zacks Consensus Estimate of 38 cents. Revenues totaled $946.2 million and surpassed the Zacks Consensus Estimate of $917.1 million. The stock currently carries a Zacks Rank #2.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
What's in Store for Patterson Companies (PDCO) in Q4 Earnings?
Patterson Companies, Inc.’s (PDCO - Free Report) fourth-quarter fiscal 2019 results are expected to release on Jun 27, before the market opens. While its core segments — Patterson Dental and Animal Health — are expected to impress, a narrowed guidance for fiscal 2019 raises concern.
The company has a negative average earnings surprise of 4.4% in the trailing four quarters.
Which Way are Estimates Headed?
For the quarter to be reported, the Zacks Consensus Estimate for revenues is pegged at $1.43 billion, suggesting growth of 2% from the year-ago reported number. The same for earnings is pinned at 40 cents, indicating a decline of 33.3% from the year-ago reported figure.
Patterson Companies, Inc. Price and EPS Surprise
Patterson Companies, Inc. price-eps-surprise | Patterson Companies, Inc. Quote
Factors to Consider
We expect consumable and private label businesses to see robust growth in the fiscal fourth quarter, thereby driving Patterson Companies’ core Animal Health segment.
Notably, management is constantly adding new capabilities to strengthen the Animal Health arm. The company has been capitalizing on significant market opportunity in Animal Health by offering a full and comprehensive suite of solutions that allow veterinarians to offer all methods of serving their customers, including home delivery with tools that drive greater levels of compliance. This is expected to drive fiscal fourth-quarter results.
Coming to Patterson Dental, the segment saw year-over-year rise in revenues in the last reported quarter, after more than two years of dismal performance. This reflects that management has been stabilizing the unit through continued investments. Additionally, the dental portfolio is also witnessing a robust demand currently.
However, a narrowed guidance for fiscal 2019 earnings per share is worrisome.
Notably, the company now expects the metric to be $1.40-$1.45 compared with the previously communicated $1.40-$1.50.
We believe that stiff competition from Henry Schein Dental, a unit of Henry Schein (HSIC - Free Report) , and pricing pressures pose as headwinds for the company.
What Does Our Model Say?
Per our proven model, a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) to deliver a positive earnings surprise in the quarter. However, this is not the case here.
Earnings ESP: Patterson Companies has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Patterson Companies currently carries a Zacks Rank #3.
Please note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revision.
Peer Releases
Here are two stocks that reported solid results in this earnings season.
Stryker Corporation (SYK - Free Report) delivered first-quarter 2019 adjusted earnings per share of $1.88, beating the Zacks Consensus Estimate by 2.2%. Revenues of $3.52 billion were in line with the Zacks Consensus Estimate. The stock presently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
DENTSPLY SIRONA Inc. (XRAY - Free Report) reported adjusted earnings per share of 49 cents in the first quarter of 2019, beating the Zacks Consensus Estimate of 38 cents. Revenues totaled $946.2 million and surpassed the Zacks Consensus Estimate of $917.1 million. The stock currently carries a Zacks Rank #2.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>